electroCore

company

About

ElectroCore develops neuromodulation therapies for the non-invasive treatment of diseases and disorders.

  • 1 - 10

Details

Last Funding Type
Series B
Last Funding Money Raised
$34M
Industries
Health Care,Medical Device,Therapeutics
Founded date
Jan 1, 2005
Number Of Employee
1 - 10
Operating Status
Active

electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology. The company’s current indications are for the preventative treatment of cluster headache and migraine and acute treatment of migraine and episodic cluster headache.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$34M
electroCore has raised a total of $34M in funding over 2 rounds. Their latest funding was raised on Nov 29, 2017 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 29, 2017 Series B $34M 3 Detail

Investors

Number of Lead Investors
Number of Investors
3
electroCore is funded by 3 investors. The Vinik Family Foundation and Knoll Capital Management are the most recent investors.
Investor Name Lead Investor Funding Round
The Vinik Family Foundation Series B
Knoll Capital Management Series B
American Investment Holdings Series B